Skip to content

Released Nov 8, 2022, after the close

10-Q filed Nov 8, 2022, 39 days after period end · 0000950170-22-023233

Q3 2022 · 10-Q
Revenue—
Net Income-$23.15MN/M vs Q3 2021N/M vs Q2 2022
EPS Diluted-$0.48N/M vs Q3 2021N/M vs Q2 2022
Operating Income-$23,401,000N/M
Operating Cash Flowderived-$19,822,000N/M
Free Cash Flowderived-$19,924,000N/M

What the release said

The release

Same quarter

MetricQ3 2022Q3 2021Q3 2020Q3 2019
Revenue—$6.25M$34.61M$4.23M
Net Income-$23.15M-$18.80M-$3.35M-$25.00M
EPS Diluted-$0.48-$0.41-$0.09-$0.96

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR